MTSR Prakiraan wutah bathi kanggo taun ngarep metsera.com

Lambang korporat lan logo Metsera (MTSR)

Metsera Inc (MTSR) is investing in the development of long-acting obesity injections, which impacts its financial profile. This chart of expected EPS growth for the coming year, provided by the GURU.Markets platform, shows a current value of -58.10. Capital optimization depends on FDA approval timelines and drug efficacy, as well as the recruitment of leading biochemists through stock option plans to accelerate development.

Metsera Corp (MTSR): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 01.02.2025 nganti 29.11.2025
Produk dadi Metsera

For Metsera Inc (MTSR), the projected net profit growth rate for n+1 reflects market expectations for EPS dynamics, accounting for the impact of inflationary costs on margins. This indicator measures expected capitalization efficiency, where the stability of active substance supplies via diversified logistics chains minimizes operational risks, directly determining the upward or downward profit trend on this chart.

Analisis perusahaan pesaing

ASND (Ascendis Pharma Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Corp|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (rhythmtx.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Akero AKRO|MoonLake Immunotherapeutics AG (MLTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CRNX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SLNO: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio|Agios (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Structure Pharma (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep MiMedx Corp MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute, Inc. RZLT|LXRX - Prakiraan wutah bathi saben saham kanggo taun ngarep|MBX Biosciences - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Altimmune Inc|AARD (Aardvark Therapeutics Corp) - Prakiraan wutah bathi saben saham kanggo taun ngarep|SGMT: Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioAge Labs, Inc.|biomeafusion.com (BMEA) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep QNCX|GUTS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep vTv Therapeutics VTVT|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluri Inc - Prakiraan wutah bathi kanggo taun ngarep|SYBX - Prakiraan wutah bathi kanggo taun ngarep|LPCN (Lipocine) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Matinas BioPharma Holdings - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Galecto Corporation (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Corporation (CTCX)|lumos-pharma.com - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ONVO (Organovo)|RDUS - Prakiraan wutah bathi saben saham kanggo taun ngarep